The forgotten people with thalassemia in the time of COVID-19: South Asian perspective.

Autor: Hossain MS; Department of Emerging and Neglected Diseases (END), Biomedical Research Foundation, Dhaka, Bangladesh. sorowar.hossain@brfbd.org.; School of Environment and Life Sciences, Independent University, Bangladesh (IUB), Dhaka, Bangladesh. sorowar.hossain@brfbd.org., Raheem E; Department of Emerging and Neglected Diseases (END), Biomedical Research Foundation, Dhaka, Bangladesh., Siddiqee MH; Department of Emerging and Neglected Diseases (END), Biomedical Research Foundation, Dhaka, Bangladesh.; Department of Mathematics and Natural Sciences (MNS), BRAC University, Dhaka, 1212, Bangladesh.
Jazyk: angličtina
Zdroj: Orphanet journal of rare diseases [Orphanet J Rare Dis] 2020 Sep 25; Vol. 15 (1), pp. 265. Date of Electronic Publication: 2020 Sep 25.
DOI: 10.1186/s13023-020-01543-0
Abstrakt: South Asia is the hotspot of beta-thalassemia, with an estimated 200,000 patients whose lives depend on regular blood transfusion. Due to COVID-19 pandemic, many countries have adopted unprecedented lockdown to minimize the spread of transmission. Restriction of nationwide human mobility and fear of COVID-19 infection has put thalassemia patients in a life-threatening situation because of an acute shortage of blood supply. As a public health preparedness strategy during a crisis like COVID-19 pandemic, the plights of thalassemia patients should be considered. Government-sponsored community blood-banks needs to be established or coverage expanded as a safety net for the thalassemia patients in lower- and middle-income countries.
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje